MML Investors Services
AXDX icon

MML Investors Services’s Accelerate Diagnostics AXDX Stock Holding History

MML Investors Services’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,119
Closed -$93K – 1899
2021
Q1 		$93K Sell
1,119
-222
-17% -$22.5K ﹤0.01% 1775
2020
Q4 		$102K Sell
1,341
-98
-7% -$8.78K ﹤0.01% 1637
2020
Q3 		$153K Sell
1,439
-1,646
-53% -$229K ﹤0.01% 1514
2020
Q2 		$468K Buy
+3,085
New +$304K 0.01% 1019

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Chicago Capital
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

MML Investors Services's AXDX Position: Q2 2021 in Review

MML Investors Services sold out of Accelerate Diagnostics (AXDX) in Q2 2021, closing a stake of 1,119 shares — an estimated $93K sold.

MML Investors Services first reported a position in AXDX in Q2 2020 and held it in 4 quarters. The position peaked at $468K in Q2 2020. 95 funds tracked by Wall St. Rank hold AXDX as of Q2 2021.

  • MML Investors Services reported no remaining Accelerate Diagnostics position as of Q2 2021 after selling out during the quarter.
  • MML Investors Services sold 1,119 Accelerate Diagnostics shares in Q2 2021, an estimated $93K.
  • MML Investors Services first reported a position in Accelerate Diagnostics in Q2 2020 and held it in 4 quarters.
  • MML Investors Services's Accelerate Diagnostics position peaked at $468K in Q2 2020.
  • 95 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2021.

Based on MML Investors Services's 13F filing for Q2 2021, filed 13 Aug 2021.